Sort
23,748 grants matching “melanoma”
Perioperative Targeted Genotyping in Glioma
$193,298Ganesh Shankar · Massachusetts General Hospital · K08 · FY2022 · NS
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis
$193,282Felicite K Noubissi · Jackson State University · U54 · FY2021 · MD
Cancer cell fusion; A mechanism driving breast tumor heterogeneity and metastasis
$193,281Felicite K Noubissi · Jackson State University · U54 · FY2024 · MD
Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma
$193,258Adrienne D Cox · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
COLUMBIA UNIVERSITY SOUTHWEST ONCOLOGY GROUP PROGRAM
$193,156Columbia University Health Sciences · U10 · FY2002 · CA
Clinical and Immunological Effects of SBRT and IL-2 in Metastatic Melanoma
$193,140Marka Crittenden · Providence Portland Medical Center · R21 · FY2013 · CA
An IL-12 family heterodimer that regulates IL-4 production by T cells
$193,125Nevil John Singh · University Of Maryland Baltimore · R21 · FY2022 · AI
OVERCOMING ALKYLTRANSFERASE-RELATED DRUG RESISTANCE
$193,114Case Western Reserve University · R01 · FY2000 · CA
Pathways from genotype and environment to melanoma
$193,042Queensland Institute Of Medical Research · R01 · FY2005 · CA
Investigation of a lectibody targeting tumor-associated oligomannose glycans
$193,023Nobuyuki Matoba · University Of Louisville · R21 · FY2019 · CA
Characterization of the oncogenic potential of circRNAs in melanoma
$192,997Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
Defining and targeting the immune-suppressive metabolic microenvironment of leptomeningeal melanoma metastases
$192,997Inna Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
Defining and targeting the epigenetic programs involved in melanoma development
$192,997Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · CA
Developmental Funds
$192,991Louis M Weiner · Georgetown University · P30 · FY2018 · CA
Developmental Funds
$192,991Louis M Weiner · Georgetown University · P30 · FY2016 · CA
TAS::75 0849::TAS SBIR TOPIC 277 - PHASE I SNAPMAPTM: A FUNCTIONAL COMPANION DIA
$192,786Adam Schayowitz · Biomarker Strategies, Llc · N43 · FY2011 · CA
Development of a high-throughput assay for measuring m6A demethylase activity
$192,702Kathryn D Meyer · Base5 Biosciences, Inc. · R41 · FY2015 · DA
Community Outreach and Engagement
$192,680Elizabeth A Chrischilles · University Of Iowa · P30 · FY2022 · CA
Community Outreach and Engagement
$192,680Elizabeth A Chrischilles · University Of Iowa · P30 · FY2021 · CA
Community Outreach and Engagement
$192,680Natoshia M. Askelson · University Of Iowa · P30 · FY2024 · CA
Community Outreach and Engagement
$192,680Natoshia M. Askelson · University Of Iowa · P30 · FY2023 · CA
Development of a Novel Immunotherapy Platform for Triple-Negative Breast Cancer
$192,653Craig M. Brackett · Roswell Park Cancer Institute Corp · R21 · FY2022 · CA
Remodeling of Dietary Fat into Protumorigenic Signaling Lipids in Cancer (PQ1)
$192,646Daniel Nomura · University Of California Berkeley · R21 · FY2012 · CA
Using MC1R genotype to impact skin cancer risk behaviors in Hispanics/Latinos
$192,638Peter A Kanetsky · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA
Modulating the immuno-metabolic interplay in liver cancer with cryoablation
$192,634Daniel Coman · Yale University · R21 · FY2023 · CA